Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Cancer Research
|
October 15, 1996
Fas expression and function in normal and malignant breast cell lines
M M Keane, S A Ettenberg, G A Lowrey, et al.
Neuroendocrinology
|
January 1, 1986
Subcutaneous administration of behaviorally effective doses of arginine vasopressin change brain AVP content only in median eminence
S N Deyo, W J Shoemaker, A Ettenberg, et al.
Brain Research
|
March 27, 1992
Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward
C L Duvauchelle, M Levitin, L A MacConell, et al.
Cancer Research
|
September 15, 1996
The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells
M M Keane, G A Lowrey, S A Ettenberg, et al.
Life Sciences
|
October 18, 1982
Effects of chronic lithium on enkephalin systems and pain responsiveness
D A Staunton, S N Deyo, W J Shoemaker, et al.
Cancer Research
|
February 11, 1999
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
M M Keane, S A Ettenberg, M M Nau, et al.
Behavioural Brain Research
|
March 1, 1983
Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
A Ettenberg, D van der Kooy, M Le Moal, et al.
Molecular Cell Biology Research Communications : MCBRC
|
November 5, 1999
cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors
S A Ettenberg, Y R Rubinstein, P Banerjee, et al.
Breast Cancer Research and Treatment
|
February 24, 2001
Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines
M M Keane, Y Rubinstein, M Cuello, et al.
Oncogene
|
June 11, 1999
cbl-3: a new mammalian cbl family protein
M M Keane, S A Ettenberg, M M Nau, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Cancer Research
|
October 15, 1996
Fas expression and function in normal and malignant breast cell lines
M M Keane, S A Ettenberg, G A Lowrey, et al.
Neuroendocrinology
|
January 1, 1986
Subcutaneous administration of behaviorally effective doses of arginine vasopressin change brain AVP content only in median eminence
S N Deyo, W J Shoemaker, A Ettenberg, et al.
Brain Research
|
March 27, 1992
Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward
C L Duvauchelle, M Levitin, L A MacConell, et al.
Cancer Research
|
September 15, 1996
The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells
M M Keane, G A Lowrey, S A Ettenberg, et al.
Life Sciences
|
October 18, 1982
Effects of chronic lithium on enkephalin systems and pain responsiveness
D A Staunton, S N Deyo, W J Shoemaker, et al.
Cancer Research
|
February 11, 1999
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
M M Keane, S A Ettenberg, M M Nau, et al.
Behavioural Brain Research
|
March 1, 1983
Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
A Ettenberg, D van der Kooy, M Le Moal, et al.
Molecular Cell Biology Research Communications : MCBRC
|
November 5, 1999
cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors
S A Ettenberg, Y R Rubinstein, P Banerjee, et al.
Breast Cancer Research and Treatment
|
February 24, 2001
Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines
M M Keane, Y Rubinstein, M Cuello, et al.
Oncogene
|
June 11, 1999
cbl-3: a new mammalian cbl family protein
M M Keane, S A Ettenberg, M M Nau, et al.
Page
of 10